Global Nonalcoholic Steatohepatitis (NASH) Therapeutics Market Report 2023: Featuring Pfizer, Inventiva, Galmed Pharma, Novo Nordisk, Galectin & More

DUBLIN, May 31, 2023 /PRNewswire/ — The “Global Nonalcoholic Steatohepatitis (NASH) Therapeutics Market Outlook to 2035” report has been added to ResearchAndMarkets.com’s offering. Global nonalcoholic steatohepatitis (NASH) therapeutics market is likely to grow at a CAGR of 18% over the…